Dr. Reddy's Laboratories Ltd.

View in App
5746.05 -39.05 ▼-0.7%

08 December 2023, 11:54:59 AM
Volume: 122,002

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.drreddys.com
Market Cap 96,115.29 Cr.
Enterprise Value(EV) 94,515.28 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 305.23 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 18.88 Trailing Twelve Months Ending 2023-09
Industry PE 38.89 Trailing Twelve Months Ending 2023-09
Book Value / Share 1,528.58 Trailing Twelve Months Ending 2023-09
Price to Book Value 3.77 Calculated using Price: 5,762.30
Dividend Yield 0.69 Period Ending 2023-03
No. of Shares Subscribed 16.68 Cr. 166,800,216 Shares
FaceValue 5
About Dr. Reddy's Laboratories Ltd.
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Dr. Reddy's Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Dr. Reddy's Laboratories Ltd. Performance

View details >>
1 Day
-0.68%
1 Week
-0.73%
1 Month
+6.32%
3 Month
+2.33%
6 Month
+22.94%
1 Year
+31.74%
2 Year
+27.11%
5 Year
+113.41%
10 Year
+137.18%

Dr. Reddy's Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 26.63 18.95 10.20 7.40 14.75 13.76 11.82 11.93 21.36
Return on Capital Employed (%) 22.70 19.55 9.77 8.21 13.66 11.12 15.49 14.59 26.22
Return on Assets (%) 13.67 11.05 6.14 4.23 8.86 9.20 8.21 8.08 15.01

Dr. Reddy's Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 9,853 12,570 12,262 12,572 14,024 15,599 17,642 19,212 23,286 25,497
Non Curr. Liab. 1,678 877 456 2,538 2,113 -808 -197 -508 -278 -167
Curr. Liab. 6,821 6,347 8,420 6,894 5,897 7,214 8,104 9,766 8,572 8,407
Minority Int.
Equity & Liab. 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 31,580 33,736
Non Curr. Assets 6,476 8,000 11,454 11,505 10,924 9,406 10,998 10,682 11,264 11,997
Curr. Assets 11,877 11,794 9,684 10,498 11,110 12,599 14,535 17,788 20,316 21,740
Misc. Exp. not W/O
Total Assets 18,353 19,794 21,138 22,004 22,034 22,005 25,548 28,470 31,580 33,736

Dr. Reddy's Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 15,023 15,568 14,196 14,281 15,448 17,517 19,048 21,545 24,670 26,766
Other Income 275 295 172 155 338 621 291 485 1,056 686
Total Income 15,298 15,863 14,368 14,436 15,786 18,138 19,339 22,030 25,725 27,452
Total Expenditure -11,530 -11,983 -11,724 -11,930 -12,270 -15,047 -15,178 -17,778 -18,321 -19,223
PBIDT 3,769 3,880 2,644 2,506 3,516 3,091 4,161 4,252 7,405 8,229
Interest -109 -83 -63 -79 -89 -98 -97 -96 -143 -150
Depreciation -760 -939 -1,027 -1,077 -1,135 -1,163 -1,229 -1,165 -1,250 -1,368
Taxation -563 -751 -297 -438 -386 140 -932 -879 -1,541 -1,642
Exceptional Items
PAT 2,336 2,108 1,257 912 1,950 2,026 1,952 2,183 4,507 5,069
Minority Interest
Share Associate 23 35 34 22
Other Related Items
Consolidated Net Profit 2,336 2,131 1,292 947 1,950 2,026 1,952 2,183 4,507 5,091
Adjusted EPS 137 125 78 57 117 122 117 131 271 305

Dr. Reddy's Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1,970 2,524 3,263 2,144 1,803 2,870 2,984 3,570 2,811 5,888
Cash Fr. Inv. -1,694 -2,265 -2,039 -1,840 -1,488 -773 -492 -2,266 -2,639 -4,137
Cash Fr. Finan. -24 -433 -1,700 -369 -444 -2,133 -2,516 -30 -242 -2,686
Net Change 251 -174 -477 -65 -129 -35 -24 1,275 -70 -936
Cash & Cash Eqvt 862 583 492 378 254 223 196 1,482 1,485 578

Dr. Reddy's Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 26.72 26.72 26.72 26.71 26.71 26.70 26.70 26.69 26.66
Public 61.24 61.75 62.05 62.92 63.21 62.77 62.00 60.76 59.32
Depository Receipts 12.05 11.53 11.23 10.37 10.08 10.53 11.30 12.54 14.02
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Dr. Reddy's Laboratories Ltd. Announcements

View details >>
Thu, 07 Dec 2023
Press Release
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 06, 2023, titled "Press Release".
Thu, 07 Dec 2023
News Verification
The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned US regulators inspect Dr Reddy's, other Indian pharma majors: Report. The response from the Company is awaited.
Wed, 06 Dec 2023
News Verification
The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned US regulators inspect Dr Reddy's, other Indian pharma majors: Report. The response from the Company is awaited.

Dr. Reddy's Laboratories Ltd. Technical Scans

View details >>
Thu, 07 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Dr. Reddy's Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,457.55 1,240.00 +0.1%
Divi's Laboratories Ltd. 99,108.71 3,694.05 -1.1%
Cipla Ltd. 98,730.88 1,217.30 -0.4%
Mankind Pharma Ltd. 80,033.56 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. 78,513.61 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. 71,120.92 2,056.40 -2.1%
Zydus Lifesciences Ltd. 66,623.28 644.85 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.42 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-09 28.59 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 62.44 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 112.57 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 53.31 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-09 23.73 644.85 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-09 3.98 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 9.50 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.08 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.60 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-09 3.56 644.85 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 644.85 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 644.85 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 644.85 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 644.85 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,694.05 -1.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,217.30 -0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,973.45 -0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,490.00 +0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.40 -2.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 644.85 -2.0%

Dr. Reddy's Laboratories Ltd. FAQ's

What is Dr. Reddy's Lab share price?
Can I buy Dr. Reddy's Lab shares now?
What is the Dividend Yield of Dr. Reddy's Lab?
What is the Market Cap of Dr. Reddy's Lab?
What are the key metrics to analyse Dr. Reddy's Lab?
What is the 52 Week High and Low of Dr. Reddy's Lab?
What is the trend of Dr. Reddy's Lab share price?